Stemedica Cell Technology
Photos
Stemedica Cell Technologies Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to the development and commercialization of progenitor cell and protein therapeutics aimed at addressing underserved medical conditions. The company utilizes a proprietary platform technology to produce a range of progenitor cell products that adhere to stringent quality standards in a cGMP licensed facility.
With a team of experienced scientists and management, Stemedica is advancing clinical trials in the United States for critical medical conditions, including ischemic stroke and Alzheimer's disease. The company remains committed to innovation and excellence in the field of regenerative medicine, exemplified by its recent leadership appointments and ongoing clinical initiatives.
Generated from the website

